Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13

Trial Status

Completed1
Recruiting2

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT07144254Phase 1Recruiting
Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
Osteosarcoma in ChildrenOsteosarcoma RecurrentRefractory Osteosarcoma+1 more
PrincipalinvestigatorStart date: 2026-01-22
NCT06492954Phase 1Recruiting
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
OsteosarcomaPulmonary Recurrence of Osteosarcoma
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07144254Phase 1PrincipalInvestigator

Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma

Osteosarcoma in ChildrenOsteosarcoma RecurrentRefractory Osteosarcoma+1 more
Recruiting
NCT03507491Phase 1StudyChair

Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors

Cancer
Completed
NCT06492954Phase 1PrincipalInvestigator

Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

OsteosarcomaPulmonary Recurrence of Osteosarcoma
Recruiting

All 3 trials loaded